Childhood cancers: open trials in Russia

• NCT05862285

  A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study

  Trial Treatment · Phase 3 · Hoffmann-La Roche

  Russian Scientific Center of Roentgenoradiology, Moscow · P.A. Herzen Oncological Inst., Moscow · Moscow City Oncology Hospital #62, Moscow · I.M.Sechenov First Moscow State Medical University (1st MSMU), Moskva

  Registry updated 2026-11-06

• NCT03340506

  Dabrafenib and/or Trametinib Rollover Study

  Trial Treatment · Phase 4 · Novartis Pharmaceuticals

  Moscow

  Registry updated 2026-11-03

• NCT04924075

  Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

  Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC

  Fed State Budgetary Inst N.N. Blokhin Med Center of Oncology MHRF (Site 0801), Moscow · Endocrinology Research Center of Rosmedtechnologies-Surgery (Site 0809), Moscow · Saint-Petersburg City Clinical Oncology Dispensary-Department of chemotherapy (Site 0803), Saint Petersburg · Saint Petersburg State University-Clinic of advanced medical technologies n. a. Nicolay I. Pirogov (Site 0805), Saint Petersburg · GBUZ Republican Clinical Oncological Dispensary (Site 0804), Ufa

  Registry updated 2026-11-03

• NCT07847190

  Paclitaxel-Bleomycin/Etoposide/Cisplatin vs Bleomycin/Etoposide/Cisplatin in Poor-prognosis Non-seminomatous Germ Cell Tumors (NSGCT) and Unfavorable Tumor Marker Decline

  Trial Treatment · Phase 2 · Blokhin's Russian Cancer Research Center

  N.N.Blokhin National Medical Research Center of Oncology, Moscow

  Registry updated 2026-10-26

• NCT07867522

  Prevention of Bile Leakage After Liver Resection in Children

  Trial Treatment · Federal Research Institute of Pediatric Hematology, Oncology and Immunology

  Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Moscow

  Registry updated 2026-10-09

• NCT04925479

  Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

  Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals

  Moscow · Saint Petersburg

  Registry updated 2026-09-25

• NCT06119867

  CompariSon Between the EuroPeAn and Japanese pathologiCal InvEstigation for Colon Cancer (SPACE)

  Trial Treatment · Phase 3 · Russian Society of Colorectal Surgeons

  Clinic of coloproctology and minimally invasive surgery, Moscow

  Registry updated 2026-08-17

• NCT04877522

  Asciminib Roll-over Study

  Trial Treatment · Phase 4 · Novartis Pharmaceuticals

  Moscow · Saint Petersburg

  Registry updated 2026-07-06

• NCT07633236

  Olanzapine in the Prevention and Treatment of Anorexia-Cachexia Syndrome in Patients Receiving Neoadjuvant/Preoperative Chemotherapy

  Trial Treatment · Phase 3 · Blokhin's Russian Cancer Research Center

  Federal State Budgetary Institution "N.N. Blokhin National Medical Research Center of Oncology" оf the Ministry of Health of the Russian Federation, Moscow

  Registry updated 2026-06-08

• NCT04043494

  International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma

  Trial Treatment · Phase 3 · University Hospital Muenster

  National Center for Pediatric Hematology, Oncology and Immunology Moscow, Moscow · Oncological center of regional Children's Hospital, Yekaterinburg

  Registry updated 2026-05-06

• NCT07375563

  Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma

  Trial Treatment · Phase 3 · Federal Research Institute of Pediatric Hematology, Oncology and Immunology

  National medical research center of pediatric haematology, oncology and immulogy named after Dmytriy Rogachyov, Moscow, 117198, Moscow

  Registry updated 2026-01-29

• NCT07366801

  Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies

  Trial Treatment · Phase 2/3 · Federal Research Institute of Pediatric Hematology, Oncology and Immunology

  National medical research center of pediatric haematology, oncology and immulogy named after Dmytriy Rogachyov, Moscow, 117198, Moscow

  Registry updated 2026-01-26

• NCT07256210

  Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation

  Trial Treatment · Phase 2 · Federal Research Institute of Pediatric Hematology, Oncology and Immunology

  Dmitry Rogachev Federal Research and Clinical Centre of Paediatric Haematology, Oncology and Immunology, Moscow

  Registry updated 2025-12-01

• NCT07232134

  The Efficacy of Therapy in Patients With Acute Myeloid Leukemia and Down Syndrome in Russia

  Trial Treatment · Phase 3 · Federal Research Institute of Pediatric Hematology, Oncology and Immunology

  This trial only enrols participants with Down syndrome

  National medical research center of pediatric haematology, oncology and immulogy named after Dmytriy Rogachyov, Moscow, 117198, Moscow

  Registry updated 2025-11-20

• NCT06938490

  Study of Colorectal Anastomosis Failures With First Sigmoid or Left Colonic Artery Preservation With D3 Lymphadenectomy

  Trial Treatment · the BELOOSTROV Clinic of High Technologies

  Beloostrov Clinic High Tech, Saint Petersburg

  Registry updated 2025-04-22

• NCT06931613

  Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment

  Trial Treatment · Phase 2 · St. Petersburg State Pavlov Medical University

  N. N. Blokhin Russian Cancer Research Center, Moscow, Russia, Moscow · Pavlov University, RM Gorbacheva Research Institute, Saint Petersburg

  Registry updated 2025-04-17

• NCT04680442

  Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction

  Trial Treatment · Phase 2 · Population Health Research Institute

  E.Meshalkin National medical research center of the Ministry of Health of the Russian Federation, Novosibirsk

  Registry updated 2025-04-06

• NCT06871007

  Nivolumab and DA-EPOCH-R in Pediatric Primary Mediastinal (Thymic) Large B-cell Lymphoma

  Trial Treatment · Phase 1/2 · St. Petersburg State Pavlov Medical University

  Dmitry Rogachev National Research Center, Moscow · Pavlov University, RM Gorbacheva Research Institute, Saint Petersburg

  Registry updated 2025-03-11

• NCT06756152

  Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis

  Trial Treatment · Phase 2/3 · Federal Research Institute of Pediatric Hematology, Oncology and Immunology

  National medical research center of pediatric haematology, oncology and immulogy named after Dmytriy Rogachyov, Moscow

  Registry updated 2025-01-01

• NCT05029531

  Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia Diagnosed From 0 to 365 Days of Life (ALL-Baby-2021)

  Trial Treatment · Phase 3 · Federal Research Institute of Pediatric Hematology, Oncology and Immunology

  Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology, Moscow

  Registry updated 2024-06-28

• NCT06296732

  Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification

  Research · Federal Research Institute of Pediatric Hematology, Oncology and Immunology

  Research Institute of Pediatric Hematology, Oncology and Immunology, Moscow

  Registry updated 2024-05-20

• NCT05539677

  Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research

  Research · N.N. Petrov National Medical Research Center of Oncology

  N.N. Petrov NMRC of Oncology, Oncoimmunology dep., Saint Petersburg

  Registry updated 2024-05-06

• NCT06071897

  Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma

  Trial Treatment · Phase 3 · Federal Research Institute of Pediatric Hematology, Oncology and Immunology

  Research Institute of Pediatric Hematology, Oncology and Immunology, Moscow

  Registry updated 2023-10-10

• NCT05518383

  B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021

  Trial Treatment · Phase 4 · Federal Research Institute of Pediatric Hematology, Oncology and Immunology

  Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology, Moscow

  Registry updated 2022-08-26

All Childhood cancers trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error